Axon CEO sells 10,000 shares above $500
Axon’s CEO reported pre-planned open-market sales totaling 10,000 shares on September 8, 2026 under a Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
AXON ENTERPRISE, INC. (AXON) reported that Chief Executive Officer and director Patrick W. Smith sold a total of 10,000 shares of common stock on September 8, 2026. The sales were executed in multiple trades at weighted average prices ranging from $501.99 to $513.38 per share under a Rule 10b5-1 trading plan adopted on May 12, 2025.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares
Net Sell
11 txns
Insider
SMITH PATRICK W
Role
CHIEF EXECUTIVE OFFICER
Sold
10,000 shs ($5.09M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 71 | $501.99 | $36K |
| Sale | Common Stock F1, F2 | 410 | $503.7367 | $207K |
| Sale | Common Stock F1, F3 | 1,104 | $505.5922 | $558K |
| Sale | Common Stock F1, F4 | 744 | $506.4781 | $377K |
| Sale | Common Stock F1, F5 | 749 | $507.476 | $380K |
| Sale | Common Stock F1, F6 | 1,774 | $508.4505 | $902K |
| Sale | Common Stock F1, F7 | 1,319 | $509.3189 | $672K |
| Sale | Common Stock F1, F8 | 1,348 | $510.587 | $688K |
| Sale | Common Stock F1, F9 | 1,251 | $511.4341 | $640K |
| Sale | Common Stock F1, F10 | 1,033 | $512.7022 | $530K |
| Sale | Common Stock F1, F11 | 197 | $513.3808 | $101K |
Holdings After Transaction:
Common Stock — 3,118,012 shares (Direct)
Footnotes (11)
- F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
- F2. The transaction was executed in multiple trades at prices ranging from $503.46 to $504.21. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. The transaction was executed in multiple trades at prices ranging from $504.94 to $505.875. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. The transaction was executed in multiple trades at prices ranging from $505.95 to $506.885. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. The transaction was executed in multiple trades at prices ranging from $506.96 to $507.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. The transaction was executed in multiple trades at prices ranging from $507.97 to $508.95. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. The transaction was executed in multiple trades at prices ranging from $508.985 to $509.91. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. The transaction was executed in multiple trades at prices ranging from $510.045 to $511.04. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. The transaction was executed in multiple trades at prices ranging from $511.045 to $511.985. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F10. The transaction was executed in multiple trades at prices ranging from $512.19 to $513.105. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. The transaction was executed in multiple trades at prices ranging from $513.23 to $513.645. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Lowest reported weighted average sale price: $501.99 per share
Highest reported weighted average sale price: $513.38 per share
+2 more
5 metrics
Shares sold
10,000 shares
Total common shares sold by CEO on September 8, 2026
Lowest reported weighted average sale price
$501.99 per share
Common stock sale on September 8, 2026
Highest reported weighted average sale price
$513.38 per share
Common stock sale on September 8, 2026
Number of sale transactions
11 transactions
Non-derivative open-market or private sales reported
Rule 10b5-1 plan adoption date
May 12, 2025
Plan governing the September 8, 2026 sales
Key Terms
Rule 10b5-1 trading plan, weighted average sales price, open market or private transaction
3 terms
Rule 10b5-1 trading plan regulatory
"transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sales price financial
"The price reported above reflects the weighted average sales price"
open market or private transaction financial
"Sale in open market or private transaction"
FAQ
What insider transaction did AXON (Axon Enterprise, Inc.) disclose in this Form 4?
Axon Enterprise, Inc. disclosed that CEO and director Patrick W. Smith sold 10,000 shares of Axon common stock on September 8, 2026 in a series of open-market or private transactions at weighted average prices above $500 per share.
Were the September 8, 2026 AXON insider sales under a Rule 10b5-1 plan?
Yes. The Form 4 states that all transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025, indicating the trades were pre-arranged under that plan.
Did the AXON Form 4 disclose the exact trade prices for each CEO sale?
The Form 4 provides a weighted average sales price for each line item and notes that each transaction was executed in multiple trades within specific price ranges. It states the reporting person will provide full trade details upon request.
AI-generated analysis. How Rhea-AI works. Not financial advice.